Menlo Therapeutics Inc (MNLO) Stock Price & Overview
NASDAQ:MNLO
Current stock price
The current stock price of MNLO is 1.35 null. Today MNLO is down by -2.17%. In the past month the price decreased by -16.41%. In the past year, price decreased by -71.7%.
MNLO Key Statistics
- Market Cap
- 226.383M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -3.75
- Dividend Yield
- N/A
MNLO Stock Performance
MNLO Stock Chart
MNLO Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to MNLO. When comparing the yearly performance of all stocks, MNLO is a bad performer in the overall market: 96.96% of all stocks are doing better.
MNLO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MNLO. MNLO may be in some trouble as it scores bad on both profitability and health.
MNLO Earnings
MNLO Forecast & Estimates
MNLO Financial Highlights
Over the last trailing twelve months MNLO reported a non-GAAP Earnings per Share(EPS) of -3.75. The EPS decreased by -32.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -1830.82% | ||
| ROA | -188.03% | ||
| ROE | N/A | ||
| Debt/Equity | 0.46 |
MNLO Ownership
About MNLO
Company Profile
Menlo Therapeutics Inc. is a late stage biopharmaceutical company. It focused on the development of serlopitant and treatment of chronic itch and chronic refractory cough. The company's product pipeline consists of Prurigo Nodularis Itch, Atopic Dermatitis Itch, Psoriasis Itch and Refractory Chronic Cough which are in clinical stage. Menlo Therapeutics Inc. is headquartered in Redwood City, California.
Company Info
Menlo Therapeutics Inc
520 U.S. HIGHWAY 22 SUITE 204
BRIDGEWATER NJ 08807
CEO: Steven Basta
Phone: 800-775-7936
Menlo Therapeutics Inc / MNLO FAQ
What does Menlo Therapeutics Inc do?
Menlo Therapeutics Inc. is a late stage biopharmaceutical company. It focused on the development of serlopitant and treatment of chronic itch and chronic refractory cough. The company's product pipeline consists of Prurigo Nodularis Itch, Atopic Dermatitis Itch, Psoriasis Itch and Refractory Chronic Cough which are in clinical stage. Menlo Therapeutics Inc. is headquartered in Redwood City, California.
What is the current price of MNLO stock?
The current stock price of MNLO is 1.35 null. The price decreased by -2.17% in the last trading session.
What is the dividend status of Menlo Therapeutics Inc?
MNLO does not pay a dividend.
What is the ChartMill rating of Menlo Therapeutics Inc stock?
MNLO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is Menlo Therapeutics Inc worth?
Menlo Therapeutics Inc (MNLO) has a market capitalization of 226.38M null. This makes MNLO a Micro Cap stock.